Skip to search boxSkip to navigationSkip to main content

Safety and Efficacy of Stentablation with Rotational Atherectomy for the Management of Underexpanded and Undilatable Coronary Stents

  • Hoyle L. Whiteside(corresponding author)
    ,
  • Arun Nagabandi
    ,
*Corresponding author for this work
  • Medical College of Georgia
    ,
  • Mount Sinai Medical Center Miami Beach
    ,
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Introduction: Coronary stent underexpansion is associated with in-stent restenosis and few interventions are available for the management of undilatable underexpanded stents. Stentablation (SA) with rotational atherectomy (RA) is a unique application and has previously been described with encouraging results. Data regarding SA is limited to case reports and small case series; therefore, reasonable concern persists regarding procedural safety and long-term outcomes. Methods: This is a single-center retrospective study analyzing twenty consecutive patients who underwent SA with RA. The primary endpoint was procedural success and secondary endpoints included procedural safety outcomes and major adverse cardiac events (MACE) over a 12-month follow-up period. Results: Stentablation and secondary stenting were guided by intravascular ultrasound and procedural success was achieved in all cases. No in-hospital death or MACE was observed. The prevalence of MACE was 5% at 30 days as one patient developed recurrent MI without target lesion revascularization (TLR). At 12 months, MACE had occurred in 40% of patients, however this was strongly driven by a high prevalence of TLR (30%). Only one cardiac death (5%) and one additional NSTEMI were observed during the 11 additional months of follow up. Conclusion: Stentablation with RA is a feasible and effective option for the acute management of symptomatic, underexpanded, and undilatable coronary stents. SA is associated with a high rate of procedural success as well as excellent in-hospital and short-term outcomes. However, our study population demonstrated substantial MACE at 12 months which was strongly driven by TLR and associated with minimal mortality.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 985-989 (5 pages)

Journal (Volume, Issue Number)

Cardiovascular Revascularization Medicine (Volume 20, Issue 11)

Publication milestones

  • Accepted/In press - 01/01/2019
  • Published - 11/2019

Publication status

Published - 11/2019

ISSN

1553-8389

Publication IDs

  • Scopus: 85060327234
  • PubMed: 30842041

Publication metrics

Metrics

SciVal
citations
9
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
1.61
SciVal
Author count
3
SciVal
Paper percentile
87
Scopus
citations

PlumX, opens in new tab

Citation count
28
Captures
18

Funding Details

Tarun Sharma, MD, made meaningful contribution to the publication in the form of data collection which warrants acknowledgment. Otherwise, no additional acknowledgements beyond the individuals listed as authors who meet the specified conditions for authorship.